EBAMED
Geneva, Switzerland · Founded 2018 · $20.0M raised
- Headquarters
- Geneva
- Founded
- 2018
- Business Model
- B2B
- Website
- eba-med.com
- Total Funding
- $20.0M
- Last Round
- $15.7M Series AJun 2023
- Rounds
- 5
About
EBAMed is a Geneva, Switzerland-based medical device company developing innovative image-guidance and proton-therapy solutions for the non-invasive, painless treatment of heart arrhythmias via external beam ablation. Building on preclinical research from its co-founder team on using protons for arrhythmia treatment, EBAMed aims to make proton therapy a practical, non-invasive alternative to current catheter-based cardiac ablation technologies, enabling treatment at an earlier stage of disease.
Summary
EBAMED is a Biotech company based in Geneva, Switzerland, founded in 2018. It has raised $20.0M in total across 5 rounds, most recently a $15.7M Series A round in Jun 2023. Investors include Venture Kick, Panakes Partners and European Innovation Council Fund.
Funding History
Jun 2023
Sign up to see all 5 rounds
Grant through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ebamed"><img src="https://indexed.vc/api/badge/company/ebamed" alt="EBAMED on Indexed.vc" width="260" height="76" /></a>